Rwanda is currently facing its first outbreak of the lethal Marburg virus, having reported 36 cases and 11 fatalities. The World Health Organization stated this week that the outbreak poses a very high risk in Rwanda, a high risk across the African region, and a low risk globally.
What is Marburg virus?
Marburg is a virus related to Ebola that causes hemorrhagic fever, with an average fatality rate of 50%, though it has reached 88% in past outbreaks, according to the WHO. Early medical care and rehydration can improve survival chances. Symptoms typically start with a sudden high fever and severe headache, followed by vomiting, diarrhea, and uncontrolled bleeding.
The virus was first identified in 1967 in Marburg, Germany, and Belgrade, Serbia, after lab work with African green monkeys from Uganda led to human infections. Since then, outbreaks and sporadic cases have occurred in Angola, the Democratic Republic of the Congo, Kenya, South Africa, and Uganda.
How does it spread?
Marburg is transmitted to humans through prolonged exposure to mines or caves inhabited by Rousettus fruit bats. It can also spread between people through direct contact with the bodily fluids of infected individuals or with surfaces and materials contaminated by those fluids, including blood.
Is there a vaccine?
There are currently no approved vaccines or treatments for Marburg, but Rwanda's health minister has indicated that several promising candidates may enter trials soon. These include vaccines developed by non-profit organizations like the Sabin Vaccine Institute, which is collaborating with Rwandan officials, and the International AIDS Vaccine Initiative (IAVI).
Additionally, the team from Oxford University that created the AstraZeneca COVID-19 vaccine started testing its Marburg vaccine candidate this summer in the UK using similar technology.
What else is happening?
Rwanda is monitoring around 300 contacts of confirmed cases, with about 70% involving healthcare workers from two facilities in Kigali. Cases have also been reported in seven of the country’s 30 districts. The virus spreads not only in healthcare settings but also at funerals, where close contact with the deceased is common in some cultures, according to Paul Hunter, a professor at the University of East Anglia.
Is Marburg reaching new places, and why?
In 2021, Guinea reported West Africa's first case of Marburg, followed by Ghana declaring its first outbreak in 2022, and Tanzania and Equatorial Guinea in 2023. These outbreaks were generally small and controlled through public health measures. Scientists suggest the rising frequency of outbreaks may be linked to human encroachment on animal habitats. The current outbreak in Rwanda is already among the largest recorded.
World Health Organization has reported over 35,000 suspected cases of mpox across Africa in 2024, with nearly 1,000 deaths potentially linked to the disease
The WHO has approved Abbott Laboratories' mpox diagnostic test for emergency use, marking a key step in boosting testing in outbreak-hit countries. The real-time PCR test detects mpox virus DNA from skin swabs, with more tests under review to increase diagnostic availability worldwide.
The World Health Organization reports 30,000 suspected mpox cases in Africa this year, with over 800 deaths, mostly in the Democratic Republic of Congo. The World Bank is allocating $128.89 million to support ten African countries in battling the outbreak.
U.S. stocks dip as election nears, with Trump and Harris in a tight race and investors bracing for Fed policy news.
UN Deputy Secretary-General Amina Mohammed urged fair policies for clean energy minerals, highlighting the need for equity, transparency, and environmental protection as demand soars worldwide.
Retailers like Walmart are using advanced weather data to shape local promotions and inventory, adjusting prices on seasonal items like sunscreen and winter gear. New tools help companies plan amid unpredictable weather patterns driven by climate change.
AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
Ryanair has trimmed its passenger growth target for the year ending March 2026 from 215 million to 210 million due to Boeing delivery delays. Despite a reported after-tax profit of 1.79 billion euros, average fares dropped by 10% this year.
Democratic presidential candidate Kamala Harris campaigns in Michigan on Sunday while her Republican rival Donald Trump stops in three eastern battleground states just two days before elections
Democratic candidate Kamala Harris and Republican Donald Trump remain in a tight race in the country's seven battleground states
Ryanair has trimmed its passenger growth target for the year ending March 2026 from 215 million to 210 million due to Boeing delivery delays. Despite a reported after-tax profit of 1.79 billion euros, average fares dropped by 10% this year.
AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
An analysis of U.S. health claims reveals that while GLP-1 drugs like Wegovy may aid weight loss, they significantly increase medical costs—rising to $18,507 annually—without reducing obesity-related health events, raising concerns for insurers and employers.
The CDC confirms bird flu in two Washington poultry workers and ruled out infections in Missouri healthcare staff.
UK government has confirmed that disposable vapes will be banned from sale starting June 2025
Germany has detected its first case of the new mpox variant, clade 1b, in a 33-year-old man.
U.S. stocks dip as election nears, with Trump and Harris in a tight race and investors bracing for Fed policy news.
UN Deputy Secretary-General Amina Mohammed urged fair policies for clean energy minerals, highlighting the need for equity, transparency, and environmental protection as demand soars worldwide.
Retailers like Walmart are using advanced weather data to shape local promotions and inventory, adjusting prices on seasonal items like sunscreen and winter gear. New tools help companies plan amid unpredictable weather patterns driven by climate change.
AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
Ryanair has trimmed its passenger growth target for the year ending March 2026 from 215 million to 210 million due to Boeing delivery delays. Despite a reported after-tax profit of 1.79 billion euros, average fares dropped by 10% this year.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment